e-learning
resources
London 2016
Sunday, 04.09.2016
GR2 Radiology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Time as the fourth dimension of radiology: a patient with diffuse lung disease (interstitial lung disease)
Sara Piciucchi (Forlì, Italy)
Source:
International Congress 2016 – GR2 Radiology
Session:
GR2 Radiology
Session type:
Grand round
Number:
1451
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sara Piciucchi (Forlì, Italy). Time as the fourth dimension of radiology: a patient with diffuse lung disease (interstitial lung disease). International Congress 2016 – GR2 Radiology
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Diffuse lung disease in infancy: a working classification of the pediatric interstitial lung disease (pILD) multidisciplinary cooperative group
Source: Eur Respir J 2005; 26: Suppl. 49, 500s
Year: 2005
A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Measuring patient activation in an interstitial lung disease (ILD) population: an exploratory study
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
What if my lung-dominant connective tissue disease (LD-CTD) patient eventually met criteria for a definite CTD: The role of prognosis!
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Interstitial lung disease (ILD) and multicompartment assessment of CTD: where should the respiratory physician begin?
Source: Virtual Congress 2020 – Rheumatology: understanding connective tissue disease in patients with interstitial lung disease
Year: 2020
Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Clinical case on ILD: a pulmonary case with many faces: not only interstitium
Source: Annual Congress 2007 - Clinical Grand Round: an interactive session
Year: 2007
Pattern and impact of rheumatology referral in patients with ILD and autoimmune features
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Teleradiology in interstitial lung disease: first experiences
Source: International Congress 2017 – Rare diseases
Year: 2017
Study of factors affecting mortality in ILD cases over 2 years
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
UIP-like or NSIP pattern in interstitial lung disease patients (ILD), following by ‘connective tissue disease ‘(CTD)
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012
Safety and advantages of VATS biopsy in diagnosis of interstitial lung disease
Source: International Congress 2015 – Challenges in surgery for non-malignant disorders: pleural mediastinal and tracheal problems, congenital disorders
Year: 2015
Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up?
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Neurofibromatosis-associated lung disease: a case series and literature review
Source: Eur Respir J 2007; 29: 210-214
Year: 2007
A review of patients following a diagnosis of unclassified interstitial lung disease (ILD) at a tertiary centre
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020
The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept